We are live on ! Find out more
VHAQ.RT

Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT

Delisted

VHAQ.RT was delisted on the 20th of February, 2024.

30 hedge funds and large institutions have $1.3M invested in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 3230 (-2)

27% less capital invested

Capital invested by funds: $1.79M → $1.3M (-$490K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
4
Closed
3
Calls
$448K
Puts
Net Calls
+$448K
Net Calls Change
+$6K
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$167K
KC
2
Kepos Capital
New York
$116K
KPF
3
K2 Principal Fund
Ontario, Canada
$100K
MI
4
MMCAP International
Cayman Islands
$100K
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$92K
BCM
6
Basso Capital Management
Connecticut
$69K
OCAM
7
Owl Creek Asset Management
New York
$66K
BFM
8
Boothbay Fund Management
New York
$65K
ASM
9
ATW SPAC Management
New York
$64K
M
10
Murchinson
Ontario, Canada
$64K
CH
11
CVI Holdings
Delaware
$56K
SCM
12
Shaolin Capital Management
Florida
$50K
BCM
13
Bluefin Capital Management
New York
$41K -$2.02K -15,100 -3%
MP
14
Mangrove Partners
Connecticut
$38K
LA
15
Linden Advisors
New York
$35K
SIA
16
SkyView Investment Advisors
New Jersey
$31K
Hudson Bay Capital Management
17
Hudson Bay Capital Management
Connecticut
$24K -$26.7K -200,000 -40%
PC
18
Periscope Capital
Ontario, Canada
$21K
NM
19
Newtyn Management
New York
$20K +$33.4K +250,000 New
CAC
20
Cowen and Company
New York
$19K +$2.37K +17,773 +8%
RCM
21
Rivernorth Capital Management
Florida
$14K
CS
22
Clear Street
New York
$11K -$27 -200 -0.1%
GF
23
Gabelli Funds
New York
$9K
LCM
24
Landscape Capital Management
New Jersey
$9K
GCIA
25
Gabelli & Co Investment Advisers
New York
$7K

VHAQ.RT Hedge Fund Activity: Q2 2022 in Review

30 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) for Q2 2022, worth a combined $1.3M — down 27% from $1.79M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of VHAQ.RT and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Newtyn Management, opening a new position worth an estimated $33.4K. The largest seller was Hudson Bay Capital Management, cutting an estimated $26.7K.

  • 30 institutional investors held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) as of Q2 2022, down from 32 in Q1 2022.
  • Funds reported $1.3M of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock stock for Q2 2022, down 27% quarter-over-quarter.
  • 1 fund opened new Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock positions in Q2 2022 and 3 closed out, a net change of -2 holders.
  • The largest Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock buyer in Q2 2022 was Newtyn Management, an estimated $33.4K added.
  • The largest Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock seller in Q2 2022 was Hudson Bay Capital Management, an estimated $26.7K sold.

Based on aggregated 13F filings for Q2 2022.